Kang, J. H., Ahn, M., Kim, D., Cho, E. K., Kim, J., Shin, S. W., . . . Park, K. (2016). Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial. Cancer Res Treat.
Dyfyniad Arddull ChicagoKang, Jin Hyoung, et al. "Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed By Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients With Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial." Cancer Res Treat 2016.
Dyfyniad MLAKang, Jin Hyoung, et al. "Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed By Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients With Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial." Cancer Res Treat 2016.